| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 12.02.
| Johnson & Johnson: A Reliable Dividend Growth Stock | | 3 | Seeking Alpha |
| 09.02.
| Johnson & Johnson to Participate in 2012 Leerink Swann Global Health Care Conference | | 31 | PR Newswire |
| NEW BRUNSWICK, N.J., Feb. 9, 2012 /PRNewswire/ --Johnson & Johnson (NYSE: JNJ)will participate in the 2012 Leerink Swann Global Health Care Conference on Thursday, Feb. 16, at The...
Mehr lesen zu:
Johnson & Johnson to Participate in 2012 Leerink Swann Global Health Care Conference | |
| 09.02.
| Johnson & Johnson Breaks Through Support at $65.11 | | 3 | SmarTrend |
| 09.02.
| Dreifach-Sorry: Johnson & Johnson singt enttäuschten OB-Kundinnen ein Ständchen | | 14 | HORIZONT.NET |
| 09.02.
| Dreifach-Sorry: Johnson & Johnson umwirbt enttäuschte OB-Kundinnen mit persönlichem Entschuldigungslied | | 5 | HORIZONT.NET |
| 07.02.
| The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Eli Lilly, Johnson & Johnson, Pfizer and AstraZeneca | | 61 | PR Newswire |
| CHICAGO, Feb. 7, 2012 /PRNewswire/ --Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting...
Mehr lesen zu:
The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Eli Lilly, Johnson & Johnson, Pfizer and AstraZeneca | |
| 06.02.
| Johnson & Johnson Bearish Moving Average Crossover Alert | | 3 | SmarTrend |
| 06.02.
| Johnson & Johnson Crosses Pivot Point Support at $65.44 | | 1 | SmarTrend |
| 06.02.
| The Zacks Analyst Blog Highlights: Alkermes plc, Elan, Johnson & Johnson, Amylin Pharmaceuticals and Eli Lilly & Company | | 86 | PR Newswire |
| CHICAGO, Feb. 6, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...
Mehr lesen zu:
The Zacks Analyst Blog Highlights: Alkermes plc, Elan, Johnson & Johnson, Amylin Pharmaceuticals and Eli Lilly & Company | |
| 06.02.
| Johnson&Johnson Aktie: Bei welchen Kursen wieder neu einsteigen? | | 19 | MoneyMoney |
| 03.02.
| Earnings Scorecard: Johnson & Johnson | | 8 | Zacks |
| 03.02.
| ANALYSE: Landesbank Berlin lässt Johnson & Johnson auf "Kaufen" | | 83 | dpa-AFX |
| Die Landesbank Berlin hat ihre Empfehlung
für Johnson & Johnson (JNJ) nach Zahlen zum
vierten Quartal auf "Kaufen" mit dem Ziel 75,00 (Kurs: 65,64)
US-Dollar gelassen. Der Pharma-, Medizintechnik-...
Mehr lesen zu:
ANALYSE: Landesbank Berlin lässt Johnson & Johnson auf "Kaufen" | |
| 02.02.
| J&J Hid Risperdal Studies to Boost Drug Sales, Lawyer Says | | - | Business Week |
| 01.02.
| 1 Reason Johnson & Johnson Looks Less Attractive | | 18 | Motley Fool |
| 31.01.
| 2 execs out at J&J's troubled consumer business | | 6 | Yahoo-USA |
| 31.01.
| Mylan's Staggering Upside Dwarfs J&J, Endo | | 1 | Seeking Alpha |
| 31.01.
| Johnson & Johnson Shifts Management Again in Consumer Unit Hit by Recalls | | 4 | Bloomberg |
| 31.01.
| 5-Star Stocks Poised to Pop: Johnson & Johnson | | 6 | Motley Fool |
| 31.01.
| Dendreon's Provenge And JNJ's Zytiga Both Had Strong Early Sales | | 5 | Seeking Alpha |
| 31.01.
| WSJ: J&J Initiates Management Changes At McNeil Again | | 58 | AFX News |
| NEW BRUNSWICK (dpa-AFX) - Healthcare giant Johnson & Johnson (JNJ) is
bringing about management changes at its troubled consumer drug unit McNeil, the
Wall Street Journal reported.
The...
Mehr lesen zu:
WSJ: J&J Initiates Management Changes At McNeil Again | |
